C4X Discovery Holdings PLC's (LON:C4XD) Clive Dix speaks to Proactive London's Andrew Scott following the news they've raised around £6.6mln to strengthen its balance sheet amid ongoing licensing discussions for its early-stage drug candidates.
While expressing regret for the level at which the funds were raised, Dix says they need to have a good level of cash in the bank while partnering discussions are taking place.
On the current valuation of the business, Dix says: ''It's a bargain for anyone who knows and understands the healthcare sector well''.
''For people that don't they may get shocked that it takes time, but if you're a slightly longer term investor who understands the healthcare space this is one of the best companies to invest in''.
''I've been in this business a long time and I look at all the others ... I put my money behind this and have on a regular basis''.